E-selectin S128R polymorphism and severe coronary artery disease in Arabs
Khaled K Abu-Amero1, Olayan M Al-Boudari, Gamal H Mohamed
1Genetics Department, King Faisal Specialist Hospital and Research Centre (MBC-03), P, O, Box 3354, Riyadh 11211, Saudi Arabia. kamero@kfshrc.edu.sa
Insights
The E-selectin S128R polymorphism is linked to coronary artery disease (CAD) in Saudi Arabs. While univariate analysis showed an association, it was not significant in multivariate analysis for CAD risk factors.
Area of Science:
- Genetics
- Cardiovascular Disease
- Molecular Biology
Background:
- The E-selectin p. S128R (g. A561C) polymorphism has been linked to coronary artery disease (CAD) in various populations.
- Limited data exists on the association between this E-selectin polymorphism and CAD in Arab populations.
Purpose of the Study:
- To investigate the relevance of the E-selectin S128R polymorphism in severe CAD among Saudi Arabs.
- To examine the association between this polymorphism and CAD risk factors in the Saudi population.
Main Methods:
- Genotyping of Saudi Arabs for the E-selectin S128R polymorphism using PCR and restriction enzyme digestion.
- Analysis of 556 patients with severe CAD and 237 angiographically confirmed control subjects.
Main Results:
- The frequency of the mutant 128R allele was significantly higher in CAD patients (11%) compared to controls (6%) (OR=1.76, p=0.007).
- Univariate analysis indicated a significant association between the 128R allele and CAD.
- Multivariate analysis, including CAD risk factors, did not show a significant association for the 128R allele.
Conclusions:
- The E-selectin p. S128R (g. A561C) polymorphism was associated with angiographic CAD in Saudi Arabs via univariate analysis.
- This association was not maintained in multivariate analysis when considering CAD risk factors.
Background:
The E-selectin p. S128R (g. A561C) polymorphism has been associated with the presence of angiographic coronary artery disease (CAD) in some populations, but no data is currently available on its association with CAD in Arabs.
Methods:
In the present study, we determined the potential relevance of the E-selectin S128R polymorphism for severe CAD and its associated risk factors among Arabs. We genotyped Saudi Arabs for this polymorphism by PCR, followed by restriction enzyme digestion.
Results:
The polymorphism was determined in 556 angiographically confirmed severe CAD patients and 237 control subjects with no CAD as established angiographically (CON). Frequencies of the S/S, S/R and R/R genotypes were found as 81.1%, 16.6% and 2.3% in CAD patients and 87.8%, 11.8%, and 0.4% in CON subjects, respectively. The frequency of the mutant 128R allele was higher among CAD patients compared to CON group (11% vs. 6%; odds ratio = 1.76; 95% CI 1.14 - 2.72; p = .007), thus indicating a significant association of the 128R allele with CAD among our population. However, the stepwise logistic regression for the 128R allele and different CAD risk factors showed no significant association.
Conclusion:
Among the Saudi population, The E-selectin p. S128R (g. A561C) polymorphism was associated with angiographic CAD in Univariate analysis, but lost its association in multivariate analysis.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Selectins
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests


